Cargando…

Enhancing NAD(+) Metabolome in Cardiovascular Diseases: Promises and Considerations

Detalles Bibliográficos
Autores principales:	Jahan, Fahmida, Bagchi, Rushita A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429781/ https://www.ncbi.nlm.nih.gov/pubmed/34513955 http://dx.doi.org/10.3389/fcvm.2021.716989

Ejemplares similares

3D Tissue-Engineered Vascular Drug Screening Platforms: Promise and Considerations
por: Marei, Isra, et al.
Publicado: (2022)

Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score
por: Dehghanbanadaki, Hojat, et al.
Publicado: (2023)

Cardiovascular Aging and Physical Activity: Insights From Metabolomics
por: Lim, Ryan Mao Heng, et al.
Publicado: (2021)

The healing power of music: a promising new avenue for cardiovascular health
por: Bendayan, Solomon
Publicado: (2023)

Editorial: Non-Invasive Measures of Cardiovascular Function and Health: Special Considerations for Assessing Lifestyle Behaviours
por: Fryer, Simon, et al.
Publicado: (2022)

A Primer on Repeated Sitting Exposure and the Cardiovascular System: Considerations for Study Design, Analysis, Interpretation, and Translation
por: Stoner, Lee, et al.
Publicado: (2021)

Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes
por: Hu, Xiaomin, et al.
Publicado: (2022)

Innovative Approaches to Assess Intermediate Cardiovascular Risk Subjects: A Review From Clinical to Metabolomics Strategies
por: Martins, Aline M. A., et al.
Publicado: (2021)

Considerations of valvular heart disease in children with ventricular assist devices
por: Si, Ming-Sing, et al.
Publicado: (2023)

Ideal Cardiovascular Health in Young Adults With Established Cardiovascular Diseases
por: Leopold, Jane A., et al.
Publicado: (2022)

Transcatheter Treatment of Bicuspid Aortic Valve Disease: Imaging and Interventional Considerations
por: Das, Rajiv, et al.
Publicado: (2018)

Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease
por: Wong, Yuen-Kwun, et al.
Publicado: (2021)

Bibliometric and Visual Analysis on Metabolomics in Coronary Artery Disease Research
por: Yu, Ning, et al.
Publicado: (2022)

Metabolomics and random forests in patients with complex congenital heart disease
por: Michel, Miriam, et al.
Publicado: (2022)

Corrigendum: Bibliometric and Visual Analysis on Metabolomics in Coronary Artery Disease Research
por: Yu, Ning, et al.
Publicado: (2022)

Editorial: Immunomodulatory Approaches in Cardiovascular Diseases
por: Booz, George W., et al.
Publicado: (2022)

Roles of Ferroptosis in Cardiovascular Diseases
por: Guo, Yuting, et al.
Publicado: (2022)

Editorial: Hypoxia in cardiovascular disease
por: Bilo, Grzegorz, et al.
Publicado: (2022)

Editorial: Autoimmunity and cardiovascular diseases
por: Khandker, Shahad Saif, et al.
Publicado: (2023)

NAD(+) Homeostasis in Diabetic Kidney Disease
por: Xu, Jing, et al.
Publicado: (2021)

Special Considerations in the Care of Women With Advanced Heart Failure
por: Ebong, Imo A., et al.
Publicado: (2022)

Analysis of Biomarkers for Congenital Heart Disease Based on Maternal Amniotic Fluid Metabolomics
por: Li, Yahong, et al.
Publicado: (2021)

Biomarker Discovery in Atherosclerotic Diseases Using Quantitative Nuclear Magnetic Resonance Metabolomics
por: Ma, Shuai, et al.
Publicado: (2021)

Anemia of Chronic Disease in Patients With Cardiovascular Disease
por: Lanser, Lukas, et al.
Publicado: (2021)

The promise of pulsed field ablation and the challenges ahead
por: Iyengar, Shruti Krishna, et al.
Publicado: (2023)

Editorial: Cardiogenic Shock: Basic and Clinical Considerations
por: Acharya, Deepak, et al.
Publicado: (2021)

Editorial: Classical and Novel Biomarkers for Cardiovascular Disease
por: Perticone, Maria, et al.
Publicado: (2022)

Chemokine Receptor Activation Enhances Memory B Cell Class Switching Linked to IgE Sensitization to Alpha Gal and Cardiovascular Disease
por: Pattarabanjird, Tanyaporn, et al.
Publicado: (2022)

Editorial: Physical activity and exercise for the prevention and management of cardiovascular risk and cardiovascular disease
por: Volterrani, Maurizio, et al.
Publicado: (2023)

Editorial: Bio-materials for Cardiovascular Diseases
por: Campagnolo, Paola, et al.
Publicado: (2021)

Editorial: Mitochondrial Dysfunction and Cardiovascular Diseases
por: Sadoshima, Junichi, et al.
Publicado: (2021)

Iron in Cardiovascular Disease: Challenges and Potentials
por: Li, Shizhen, et al.
Publicado: (2021)

Anti-inflammatory Nanomedicine for Cardiovascular Disease
por: Katsuki, Shunsuke, et al.
Publicado: (2017)

Platelet-Derived Microvesicles in Cardiovascular Diseases
por: Zaldivia, Maria T. K., et al.
Publicado: (2017)

Genetics of Cardiovascular Disease: Fishing for Causality
por: Paone, Christoph, et al.
Publicado: (2018)

Vascular Senescence in Cardiovascular and Metabolic Diseases
por: Katsuumi, Goro, et al.
Publicado: (2018)

Experimental Rodent Models of Cardiovascular Diseases
por: Jia, Tian, et al.
Publicado: (2020)

Editorial: Epigenetic Regulation in Cardiovascular Diseases
por: Pillai, Indulekha C. L., et al.
Publicado: (2022)

Pyroptosis: Role and Mechanisms in Cardiovascular Disease
por: Chen, Xinzhe, et al.
Publicado: (2022)

Editorial: Cardiovascular involvement in autoimmune diseases
por: Mavrogeni, Sophie I., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r3qffjg6ijt6utvn5rtaoee1ii